Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cummins | CMI | Sep 23, 2024 | 313.48 | +1.70 |
Cumulus Media A | CMLS | Sep 23, 2024 | 1.42 | -6.58 |
Curevac N.V. | CVAC | Sep 23, 2024 | 3.09 | -4.33 |
CuriosityStream | CURI | Sep 23, 2024 | 1.83 | 0.00 |
Curis | CRIS | Sep 23, 2024 | 5.64 | -4.57 |
CURRENC Group | CURR | Sep 23, 2024 | 2.80 | 0.00 |
Curtiss-Wright | CW | Sep 23, 2024 | 332.22 | +1.13 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Sep 23, 2024 | 43.73 | +1.20 |
Cushman & Wakefield | CWK | Sep 23, 2024 | 13.48 | +0.37 |
Custom Truck One Source | CTOS | Sep 23, 2024 | 3.65 | -1.62 |
Customers Bancorp | CUBI | Sep 23, 2024 | 47.00 | -1.47 |
Customers Bancorp E Pref | CUBI-E | Sep 23, 2024 | 25.35 | -0.08 |
Customers Bancorp F Pref | CUBI-F | Sep 23, 2024 | 25.15 | -0.14 |
Cutera | CUTR | Sep 23, 2024 | 0.70 | -7.72 |
CVB Financial | CVBF | Sep 23, 2024 | 18.14 | -0.60 |
CVD Equipment | CVV | Sep 23, 2024 | 3.27 | -0.61 |
CVR Energy | CVI | Sep 23, 2024 | 23.41 | -0.26 |
Cvr Partners LP Unit | UAN | Sep 23, 2024 | 68.73 | -1.74 |
CVRx | CVRX | Sep 23, 2024 | 9.01 | -1.10 |
CVS Health | CVS | Sep 23, 2024 | 57.57 | +0.10 |
CXApp A | CXAI | Sep 23, 2024 | 1.70 | -4.49 |
CyberArk Software | CYBR | Sep 23, 2024 | 284.19 | +1.27 |
Cybin | CYBN | Sep 23, 2024 | 9.63 | +4.90 |
Cyclacel Pharmaceuticals | CYCC | Sep 23, 2024 | 0.99 | +1.02 |
Cyclacel Pharmaceuticals Pref | CYCCP | Sep 23, 2024 | 7.00 | 0.00 |
Cyclerion Therapeutics | CYCN | Sep 23, 2024 | 2.75 | -6.14 |
Cyclo Therapeutics | CYTH | Sep 23, 2024 | 0.70 | -1.83 |
Cyngn | CYN | Sep 23, 2024 | 3.40 | -6.59 |
Cytek Biosciences | CTKB | Sep 23, 2024 | 5.19 | +1.96 |
Cytokinetics | CYTK | Sep 23, 2024 | 52.09 | -3.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.